Financials
- Market Capitalization 259.1 M
- Employee 389
- Founded 1999
- CEO N/A
- Website www.standardbio.com
- Headquarter Delaware, United States
- FIGI BBG000S8WQB6
- Industry 診断・研究
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-6.4
売上高対価格比率
5.73
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3080 | PRE Prenetics Global Limited - Class A Ordinary Share | 21.27 USD | +0.52% | +4.26% | -11.52% | +52.91% | 358.91 M USD | ||
| 3341 | BDSX Biodesix, Inc. - Common Stock | 25.00 USD | -2.72% | -9.09% | -8.76% | +99.84% | 263.78 M USD | ||
| 3517 | XGN Exagen Inc. - Common Stock | 8.48 USD | +2.79% | +6.27% | +15.85% | -27.21% | 205.43 M USD | ||
| 3635 | BNR Burning Rock Biotech Limited - American Depositary Shares | 15.00 USD | -0.66% | -3.97% | +27.99% | -49.87% | 162.31 M USD |